Skip to content

Analgesic Efficacy of Intrathecal Fentanyl-Morphine Combination Versus Morphine Alone for Intraoperative Pain During Elective Cesarean Delivery

Analgesic Efficacy of Intrathecal Fentanyl-Morphine Combination Versus Morphine Alone for Intraoperative Pain During Elective Cesarean Delivery: a Randomized Clinical Trial

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06570343
Enrollment
186
Registered
2024-08-26
Start date
2024-09-20
Completion date
2025-12-25
Last updated
2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative Pain

Brief summary

Pregnant women scheduled for elective cesarean sections under spinal anesthesia are randomly assigned to two groups: 1) the Fentanyl-Morphine (FM) group, and 2) the Morphine (M) group. In addition to 11.5 mg of bupivacaine, the FM group receives 15 μg of fentanyl and 50 μg of morphine intrathecally, while the M group receives 50 μg of morphine intrathecally. The incidence of intraoperative pain with a Numerical Rating Scale (NRS) score of 4 or higher is compared between the two groups to evaluate the analgesic effects of combined intrathecal fentanyl-morphine therapy versus morphine alone.

Interventions

DRUGFentanyl-Morphine

Intrathecal injection of bupivacaine, fentanyl and morphine

DRUGMorphine

Intrathecal injection of bupivacaine and morphine

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Parturients of gestational age \> 37 weeks, scheduled for cesarean section under spinal anesthesia

Exclusion criteria

* Contraindication to spinal anesthesia * Any sign of onset of labor * Emergency cesarean section * Body weight \< 40 kg or \> 120 kg * Height \< 140 cm or \> 190 cm * Severe underlying cardiovascular disease * Known fetal anomaly * Preeclampsia * History of hypersensitivity to fentanyl or morphine * Chronic opioid use

Design outcomes

Primary

MeasureTime frameDescription
Incidence of intraoperative painFrom first skin incision to end of surgeryIncidence of intraoperative pain of NRS (numeric rating scale) score of 4 or higher

Secondary

MeasureTime frameDescription
Time of occurence of intraoperative painFrom first skin incision to end of surgeryTime of occurence of intraoperative pain of NRS (numeric rating scale) score of 4 or higher
Total amount of intraoperative opioid rescue analgesic administrationFrom first skin incision to end of surgeryTotal amount of intraoperative opioid rescue analgesic administration (morphine mg equivalent)
Total amount of intraoperative non-opioid rescue analgesic administrationFrom first skin incision to end of surgeryTotal amount of intraoperative non-opioid rescue analgesic administration (mg)
Intraoperative pain characteristicsFrom first skin incision to end of surgeryIntraoperative pain characteristics
Conversion to general anesthesiaFrom first skin incision to end of surgeryConversion to general anesthesia
Preoperative anxietyOn the day before surgeryPreoperative anxiety (APAIS, Amsterdam Preoperative Anxiety and Information Score)
Total amount of postoperative opioid analgesic administeredFrom end of surgery to 24 hours after end of surgeryTotal amount of postoperative opioid analgesic administered (morphine mg equivalent)
Incidence of intraoperative nausea/vomitingFrom induction to end of surgeryIncidence of intraoperative nausea/vomiting
Incidence of postoperative nausea/vomitingFrom end of surgery to 24h post-surgeryIncidence of postoperative nausea/vomiting
Incidence of intraoperative shiveringFrom induction to end of surgeryIncidence of intraoperative shivering
Incidence of intraoperative hypotensionFrom induction to end of surgeryIncidence of intraoperative hypotension (MBP\<65 mmHg)
Incidence of intraoperative rescue analgesic administrationFrom first skin incision to end of surgeryIncidence of intraoperative rescue analgesic administration
Incidence of postoperative pruritusFrom end of surgery to 24h post-surgeryIncidence of postoperative pruritus
Immediate post-operative patient satisfactionAt the end of surgeryImmediate post-operative patient satisfaction on intraoperative analgesia
Obstetric Quality of Recovery-11K scoreAt 24 hours post-surgeryObstetric Quality of Recovery-11K score
Time of first postoperative painFrom end of surgery to 24 hours post-surgeryTime of first postoperative pain
Pain score at 8 hours post-surgeryat 8 hours post-surgeryPain score at 8 hours post-surgery (NRS, numeric rating scale pain score, 0: no pain; 10: worst imaginable pain)
Pain score at 16 hours post-surgeryat 16 hours post-surgeryPain score at 16 hours post-surgery (NRS, numeric rating scale pain score, 0: no pain; 10: worst imaginable pain)
Pain score at 24 hours post-surgeryat 24 hours post-surgeryPain score at 24 hours post-surgery (NRS, numeric rating scale pain score, 0: no pain; 10: worst imaginable pain)
Pain score at 2 hours post-surgeryat 2 hours post-surgeryPain score at 2 hours post-surgery (NRS, numeric rating scale pain score, 0: no pain; 10: worst imaginable pain)
Incidence of postoperative hypotensionFrom end of surgery to 24 hours post-surgeryIncidence of postoperative hypotension (MBP<65 mmHg)
Incidence of postoperative shiveringFrom end of surgery to 24 hours post-surgeryIncidence of postoperative shivering
24-hour post-operative patient satisfactionat 24 hours post-surgery24-hour post-operative patient satisfaction on postoperative analgesia
Incidence of intraoperative pruritusFrom induction to end of surgeryIncidence of intraoperative pruritus

Contacts

Primary ContactJin-Tae Kim, M.D., Ph.D
jintae73@gmail.com+82-2-2072-2467

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026